Navigating the 2021 update to the IDSA/SHEA guidelines: An ethical approach to equitable patient care.

Antimicrob Steward Healthc Epidemiol

Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.

Published: April 2022

The 2021 focused update to the Infections Diseases Society of America/Society for Healthcare Epidemiology of America (IDSA/SHEA) guidelines for management of infection (CDI) prioritizes the use of fidaxomicin over vancomycin for the treatment of initial and recurrent CDI. These recommendations have significant clinical and financial ramifications for hospitals and patients with CDI. Antimicrobial stewardship programs must balance the needs, goals, and barriers faced by patients and health systems when determining the best treatment strategy for CDI. In this commentary, we provide antimicrobial stewardship programs with a decision-making framework that acknowledges the fundamental principles of ethics to provide equitable patient care.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726573PMC
http://dx.doi.org/10.1017/ash.2022.49DOI Listing

Publication Analysis

Top Keywords

idsa/shea guidelines
8
equitable patient
8
patient care
8
antimicrobial stewardship
8
stewardship programs
8
navigating 2021
4
2021 update
4
update idsa/shea
4
guidelines ethical
4
ethical approach
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!